Professor Kari Tanderup, PhD, Department of Oncology, Aarhus University Hospital in Aarhus, Denmark. Kari Tanderup’s main research interests are MRI guided cervix cancer, clinical studies, imaging, and in vivo dosimetry. Within these topics she has authored 130+ papers and has supervised 10+ PhD students. Kari Tanderup is actively contributing to committee and task group work in ESTRO and is course director in the ESTRO school. She is chairing the GEC ESTRO gyn network which represents the most active core European academic centers within gynecological brachytherapy, and embraces members from Central/Eastern Europe, India, Canada and USA. Through past and on-going activities this group is internationally recognized as a leading group in gynecological image guided brachytherapy. The group has published international guidelines, which are now used worldwide. The GEC ESTRO gyn group has also initiated the EMBRACE studies. EMBRACE I is an international multicenter study on MRI guided brachytherapy in cervix cancer. The EMBRACE I trial has recruited 1416 patients in the period 2008-2015, and this material is currently generating a wealth of clinical evidence on outcome as well as dose and effect relationships. In 2016, the EMBRACE II study was initiated which is a prospective interventional study, which will enroll 1000 patients over 4 years. EMBRACE II is benchmarking advanced EBRT (IMRT and IGRT) and BT (prescription protocol and advanced applicators).